Immix Biopharma | Investor Presentation Deck | 56 slides · page 26 of 56
The diagram shows a summation of two patient groups (prevalence and incidence-derived relapsed/refractory) to reach a total eligible patient count.
Pitch deck · market_sizing · size_opportunity · balanced density
Slide locked Sign in to view
Slide schematic 3/3
diagram 1/1 source-note 1/1 title 1/1
Components 3
process source-note headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1